S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Sell every Stock except ONE (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
Sell every Stock except ONE (Ad)
NYSE:ABT

Abbott Laboratories - ABT SEC Filings & 10K Form

$111.48
+0.99 (+0.90%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$110.44
$111.53
50-Day Range
$102.07
$116.88
52-Week Range
$101.24
$142.60
Volume
2.80 million shs
Average Volume
5.56 million shs
Market Capitalization
$195.23 billion
P/E Ratio
23.27
Dividend Yield
1.70%
Price Target
$132.46

Recent Abbott Laboratories SEC Filings

DateFilerForm TypeView
08/03/2022
11:27 AM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/28/2022
4:20 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2022
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2022
3:36 PM
Abbott Laboratories (Issuer)
Tyler Julie L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
3:34 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
3:32 PM
Abbott Laboratories (Issuer)
Calamari Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
3:28 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:57 PM
Abbott Laboratories (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/14/2022
4:18 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2022
4:16 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2022
4:14 PM
Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2022
3:11 PM
Abbott Laboratories (Filer)
Form SD
Specialized Disclosure Report  
05/05/2022
5:12 PM
Abbott Laboratories (Issuer)
WOODGRIFT RANDEL WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2022
4:15 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
5:36 PM
Abbott Laboratories (Issuer)
TILTON GLENN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
5:32 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
5:23 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
5:18 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
5:12 PM
Abbott Laboratories (Issuer)
OSBORN WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
5:09 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
5:00 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
4:57 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
4:54 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
4:52 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2022
4:49 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2022
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2021
5:13 PM
Abbott Laboratories (Issuer)
PEDERSON MICHAEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2021
4:28 PM
Abbott Laboratories (Issuer)
WOODGRIFT RANDEL WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
4:20 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
4:19 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/01/2021
6:11 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2021
4:18 PM
Abbott Laboratories (Issuer)
LANE ANDREW H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
4:40 PM
Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
3:01 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2021
6:22 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2021
4:32 PM
Abbott Laboratories (Issuer)
Tyler Julie L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2021
4:26 PM
Abbott Laboratories (Issuer)
Tyler Julie L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2021
4:08 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
4:15 PM
Abbott Laboratories (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/11/2021
4:09 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:33 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:31 PM
Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
7:12 AM
Abbott Laboratories (Filer)
Form SD
Specialized Disclosure Report  
05/04/2021
6:07 PM
Abbott Laboratories (Issuer)
Watkin Jared (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2021
4:38 PM
Abbott Laboratories (Issuer)
Funck Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
5:42 PM
Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
5:38 PM
Abbott Laboratories (Issuer)
BIRD ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:18 PM
Abbott Laboratories (Issuer)
TILTON GLENN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:16 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:15 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:13 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:11 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/27/2021
6:09 PM
Abbott Laboratories (Issuer)
OSBORN WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:08 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:06 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:05 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:03 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
6:01 PM
Abbott Laboratories (Issuer)
AUSTIN ROXANNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2021
5:59 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2021
3:16 PM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
6:38 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2021
4:39 PM
Abbott Laboratories (Issuer)
WOODGRIFT RANDEL WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:37 PM
Abbott Laboratories (Issuer)
Scoggins Christopher J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:34 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:30 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2021
8:36 PM
Abbott Laboratories (Subject)
AS YOU SOW (Filed by)
Form PX14A6G
03/12/2021
3:21 PM
Abbott Laboratories (Filer)
Form DEFA14A
03/12/2021
3:10 PM
Abbott Laboratories (Filer)
Form DEF 14A
03/05/2021
6:11 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:11 PM
Abbott Laboratories (Issuer)
WOODGRIFT RANDEL WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:08 PM
Abbott Laboratories (Issuer)
WHITE MILES D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:05 PM
Abbott Laboratories (Issuer)
Wellisch Alejandro D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:01 PM
Abbott Laboratories (Issuer)
Watkin Jared (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:59 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:55 PM
Abbott Laboratories (Issuer)
Scoggins Christopher J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:54 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:45 PM
Abbott Laboratories (Issuer)
PEDERSON MICHAEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:44 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:40 PM
Abbott Laboratories (Issuer)
MANNING JOSEPH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:36 PM
Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:33 PM
Abbott Laboratories (Issuer)
LANE ANDREW H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:30 PM
Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:23 PM
Abbott Laboratories (Issuer)
Funck Robert E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:20 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:16 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:13 PM
Abbott Laboratories (Issuer)
DALE MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:08 PM
Abbott Laboratories (Issuer)
CAPEK JOHN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
6:02 PM
Abbott Laboratories (Issuer)
BRYNELSEN CHARLES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
5:59 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
5:55 PM
Abbott Laboratories (Issuer)
BIRD ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
5:52 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
5:49 PM
Abbott Laboratories (Issuer)
Ahlberg Gregory A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
5:05 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:42 PM
Abbott Laboratories (Filer)
Form PRE 14A
02/23/2021
6:22 PM
Abbott Laboratories (Issuer)
WOODGRIFT RANDEL WILLIAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
6:20 PM
Abbott Laboratories (Issuer)
WHITE MILES D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
6:18 PM
Abbott Laboratories (Issuer)
Wellisch Alejandro D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
6:16 PM
Abbott Laboratories (Issuer)
Watkin Jared (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
6:15 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
6:12 PM
Abbott Laboratories (Issuer)
Scoggins Christopher J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NYSE:ABT) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.